Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.57 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28131851 | 1.00 | HDAC3 (0.61) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Hydrochloric Acid SCHEMBL17500942 | 0.98 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Hydrochloric Acid SCHEMBL8939068 | 0.98 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Bromide SCHEMBL27617389 | 0.98 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Methylene Chloride SCHEMBL28230710 | 0.96 | HDAC3 (0.57) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Trifluoroacetic Acid SCHEMBL27673946 | 0.88 | KMT2A (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL29136571 | 0.83 | TLR7 (0.59) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL4508472 | 0.83 | CES2 (0.64) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL1147702 | 0.83 | KDM4E (0.73) | CES2CES1SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL28218344 | 0.82 | KMT2A (0.63) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 843 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120064228-A | On-site visual fluorescence detection reagent for synthesizing cannabinoid-MDMB | 中国科学院新疆理化技术研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-119731183-A | Solid forms of macrocyclic compounds as CFTR modulators and their preparation | 弗特克斯药品有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2025020685-A1 | PEROVSKITE THIN FILM LAYER AND PREPARATION METHOD THEREFOR, AND PEROVSKITE SILICON STACKED SOLAR CELL AND PREPARATION METHOD THEREFOR | 通威太阳能（成都）有限公司 | 2025-01-30 | — | — | WO | claimed |
| US-20240335420-A1 | N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS | EUROFARMA LABORATÓRIOS S.A. (BR) | 2024-10-10 | — | — | US | claimed |
| CN-118420524-A | Pyridine hydrazide tripodia functionalized fluorescent sensor and synthesis and application thereof in detection of zinc ions | 西北民族大学 | 2024-08-02 | — | — | CN | claimed |
| EP-4382101-A1 | N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | Eurofarma Laboratórios S.A. (BR) | 2024-06-12 | — | — | EP | claimed |
| CN-117720925-A | Groove buffer etching solution for inhibiting titanium nitride corrosion | 湖北兴福电子材料股份有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-113527196-B | Be used for detecting Al 3+ And Zn 2+ Compounds of (C), preparation method and application thereof | 南京林业大学 | 2023-12-22 | — | — | CN | claimed |
| CN-116887609-A | Perovskite thin film layer and preparation method thereof, perovskite silicon laminated solar cell and preparation method thereof | 通威太阳能（成都）有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-116410441-A | Water-based polyurethane-acrylate emulsion and preparation method thereof | 万华化学集团股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-102712638-A | New phenylhydrazone derivatives and their use as pharmaceuticals | ARTERIA CORP | 2012-10-03 | — | — | CN | claimed |
| CN-100453541-C | Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof | SHENYANG RES INST CHEMICAL IND (CN) | 2009-01-21 | — | — | CN | claimed |
| CN-1927859-A | Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof | SHENYANG RES INST CHEMICAL IND (CN) | 2007-03-14 | — | — | CN | claimed |
| EP-1448553-B1 | N-HETEROCYCLYL HYDRAZIDES AS NEUROTROPHIC AGENTS | ORTHO MCNEIL PHARM INC (US) | 2005-05-04 | — | — | EP | claimed |
| EP-1448553-A1 | N-HETEROCYCLYL HYDRAZIDES AS NEUROTROPHIC AGENTS | Ortho McNeil Pharmaceutical, Inc. (US) | 2004-08-25 | — | — | EP | claimed |
| US-20030144262-A1 | N-heterocyclyl hydrazides as neurotrophic agents | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-07-31 | — | — | US | claimed |
| WO-2003029247-A1 | N-HETEROCYCLYL HYDRAZIDES AS NEUROTROPHIC AGENTS | ORTHO MC NEIL PHARMACEUTICAL, INC. (US) | 2003-04-10 | — | — | WO | claimed |
| EP-0323590-A2 | Carbazoyl derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1989-07-12 | — | — | EP | claimed |
| EP-0214158-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1987-03-18 | — | — | EP | claimed |
| WO-1986004582-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1986-08-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240335420-A1 | N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS | SCN1A, SCN1B, CACNA1B | HDAC3 141/4885HDAC4 448/4885HDAC1 120/4885 |
| US-20030144262-A1 | N-heterocyclyl hydrazides as neurotrophic agents | BDNF, NGF, GAP43 | HDAC3 2460/4885HDAC4 910/4885HDAC1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.